Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Runnebaum

Showing results (381-390 of 452) with videos related to

Pageof 46
Sort By:
Clinical Epigenetics|November 12, 2020
Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assaysCarolin Dippmann, Martina Schmitz, Kristina Wunsch, et al.
Genes, Chromosomes & Cancer|October 22, 2019
Combined assessment of 3q26 amplification and promoter methylation in patients with high grade cervical lesions show age specific differencesJosefine Beiersdorf, Cornelia Scheungraber, Kristina Wunsch, et al.
Cancer Genetics|January 31, 2012
Two novel unbalanced whole arm translocations are frequently detected in cervical squamous cell carcinomaClaudia Backsch, Birgit Pauly, Melanie Liesenfeld, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Breast Cancer Research and Treatment|January 21, 2010
The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancerDiane M Renz, Joachim Böttcher, Pascal A T Baltzer, et al.
Cancer Gene Therapy|June 26, 2002
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerRichard E Buller, Ingo B Runnebaum, Beth Y Karlan, et al.
Cancer Gene Therapy|June 26, 2002
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500Richard E Buller, Mark S Shahin, Jo Ann Horowitz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 16, 2008
[Clinical value of computer-assisted analysis in MR mammography. A comparison between two systems and three observers with different levels of experience]D M Renz, P A T Baltzer, P E Kullnig, et al.
Scientific Reports|March 1, 2020
Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancerMatthias Dietzel, Rüdiger Schulz-Wendtland, Stephan Ellmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomasB Saffari, L Bernstein, D C Hong, et al.
Pageof 46

Showing results (381-390 of 452) with videos related to

Sort By:
Pageof 46
Clinical Epigenetics|November 12, 2020
Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assaysCarolin Dippmann, Martina Schmitz, Kristina Wunsch, et al.
Genes, Chromosomes & Cancer|October 22, 2019
Combined assessment of 3q26 amplification and promoter methylation in patients with high grade cervical lesions show age specific differencesJosefine Beiersdorf, Cornelia Scheungraber, Kristina Wunsch, et al.
Cancer Genetics|January 31, 2012
Two novel unbalanced whole arm translocations are frequently detected in cervical squamous cell carcinomaClaudia Backsch, Birgit Pauly, Melanie Liesenfeld, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]D G Kieback, M F Press, S K McCamant, et al.
Breast Cancer Research and Treatment|January 21, 2010
The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancerDiane M Renz, Joachim Böttcher, Pascal A T Baltzer, et al.
Cancer Gene Therapy|June 26, 2002
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerRichard E Buller, Ingo B Runnebaum, Beth Y Karlan, et al.
Cancer Gene Therapy|June 26, 2002
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500Richard E Buller, Mark S Shahin, Jo Ann Horowitz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 16, 2008
[Clinical value of computer-assisted analysis in MR mammography. A comparison between two systems and three observers with different levels of experience]D M Renz, P A T Baltzer, P E Kullnig, et al.
Scientific Reports|March 1, 2020
Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancerMatthias Dietzel, Rüdiger Schulz-Wendtland, Stephan Ellmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomasB Saffari, L Bernstein, D C Hong, et al.
Pageof 46